91
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate

, , , , , & show all
Pages 2807-2816 | Published online: 25 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Seon-Cheol Park, Gyung-Mee Kim, Takahiro A. Kato, Mian-Yoon Chong, Shih-Ku Lin, Shu-Yu Yang, Ajit Avasthi, Sandeep Grover, Roy Abraham Kallivayalil, Yu-Tao Xiang, Kok Yoon Chee, Andi Jayalangkara Tanra, Chay Hoon Tan, Kang Sim, Norman Sartorius, Naotaka Shinfuku, Yong Chon Park & Toshiya Inada. (2021) Dyskinesia is most centrally situated in an estimated network of extrapyramidal syndrome in Asian patients with schizophrenia: findings from research on Asian psychotropic prescription patterns for antipsychotics. Nordic Journal of Psychiatry 75:1, pages 9-17.
Read now

Articles from other publishers (3)

Giuseppe Cicala, Renato de Filippis, Maria Antonietta Barbieri, Paola Maria Cutroneo, Pasquale De Fazio, Georgios Schoretsanitis & Edoardo Spina. (2023) Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database. Frontiers in Psychiatry 14.
Crossref
Zh. B. Bibekova, E. A. Strel’cov & A. S. Makarchuk. (2020) APPLICATION OF ANTIPSYCHOTICS OF LONG-TERM ACTION IN SCHIZOPHRENIA. Medical Herald of the South of Russia 11:1, pages 6-13.
Crossref
Luisa Peters, Amanda Krogmann, Laura von Hardenberg, Katja Bödeker, Viktor B. Nöhles & Christoph U. Correll. (2019) Long-Acting Injections in Schizophrenia: a 3-Year Update on Randomized Controlled Trials Published January 2016–March 2019. Current Psychiatry Reports 21:12.
Crossref